Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nucore Health vs Ro

Nucore Health
Graded #367

Lower grade

vs+21.6
Ro
Graded #38

Higher grade

The verdict

Ro takes it — 80.2/100 to 58.6/100.

Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRo +32
36
68
Dose & formulationRo +22
64
86
Clinical oversightRo +4
82
86
Labs & monitoringRo +29
53
82
FulfillmentRo +17
67
84
Contract termsRo +25
55
80
Nucore Health · left barRo · right bar

The numbers

MetricNucore HealthRo
WeighScore58.6/10080.2/100
GradeCB−
Scorecard rank#367#38
Semaglutide$299/mo (starting dose, compounded)Not disclosed
Tirzepatide$199/mo (microdose tier, compounded)Not disclosed
CoverageCoverage not publishedMulti-state
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Nucore Health

Graded #367 · C

Strengths

  • Physician-owned and LegitScript Certified — strong trust signals
  • Available nationwide in all 50 states
  • Care and pharmacy fulfillment run on OpenLoop Health's licensed network
  • Broad menu — compounded GLP-1, microdose tirzepatide, NAD+, sermorelin, MIC B12

Where it loses points

  • Published pricing is gated behind the intake quiz — no upfront cost shown
  • Legal terms and privacy are posted as downloadable documents, not web pages
  • Compounded GLP-1 is not FDA-approved and prescribed off-label (per their own notice)
  • Longevity and microdose positioning is marketing; evidence varies by use
Ro

Graded #38 · B−

Strengths

  • Brand-name access + insurance support
  • Oral options
  • Well-funded platform

Where it loses points

  • Does not disclose compounded pricing up front
  • Premium positioning

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard